p16 mutation spectrum in the premalignant condition Barrett's esophagus.
Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions.We have determined the...
Главные авторы: | , , , , , , , , |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Public Library of Science (PLoS)
2008-01-01
|
Серии: | PLoS ONE |
Online-ссылка: | http://europepmc.org/articles/PMC2585012?pdf=render |